After 13 months, the rats begin to show signs of dementia including reduced cognitive ability and memory impairment (McGill University, 2010).
Amyloid B. immunotherapy
Past research
Past research on the effects of active or passive a? immunization on a? buildup and AD progression provided evidence that such immunization "protects against the progressive loss of synaptophysin in the hippocampal molecular layer and frontal neocortex of a transgenic mouse model of AD" (Buttini & al, 2005). This provided further support for the amyloid hypothesis.
Current research
Since the discovery of a? immunotherapy effectiveness in the treatment of AD in mice, the AN1792 a? vaccine was developed and tested on humans (Lemere & Masliah, 2010). Unfortunately, clinical trials were discontinued when around 6% of the subjects developed meningoencephalitis (Lemere & Masliah, 2010). However, since some subjects showed improvements in a? plaque clearance, several new a? immunotherapies have been developed and are currently undergoing clinical trials (Lemere & Masliah, 2010). Based on preliminary results from these clinical trials, scientists predict that a? immunotherapy will be most effective in "preventing or slowing the progression of AD when patients are immunized before or in the very earliest stages" of the onset of AD (Lemere & Masliah, 2010). Therefore, current research is also focused on identifying biomarkers to predict the "presymptomatic" stages of AD (Lemere & Masliah, 2010).
Conclusion
Research on AD has made tremendous progress in the past decade, strengthening the amyloid hypothesis and providing evidence to support the development of a? immunotherapies. Further studies taking advantage of the a? rat model may provide more clues to direct the development of effective a? immunotherapies. In addition, anti-inflammatory medications and therapies should be considered for patients with AD, since numerous studies show a link between inflammation reduction and improvement in AD symptomatology.
The future also shows exciting promise for novel approaches to AD treatment. One new causal theory...
In light of the knowledge provided by these case studies, it is important to note certain flaws in the methodology of each cases study. The study in the case of midlife neuroticism, the researchers do not take into account pre- existing conditions such the brain structure and function associated with greater neuroticism. Failure to proper diagnosis might lead to early presentation of Alzheimer's disease in response to pathology. As for
Alzheimer's This brief report is a summary and review of the rather nasty degenerative brain disorder that is known as Alzheimer's. The disease has been known about for a decent amount of time but the overall progress come to when it comes to preventing or curing the disorder has become remained frustratingly slow. Even so, progress is indeed being made and more is now known about the disorder than was before.
Problem StatementThe problem to be addressed in this study is Alzheimer’s Disease (AD) is a debilitating and progressive neurodegenerative disorder estimated to affect over 5 million women in the United States, yet recent research has shown that many cases go undiagnosed (Royse et al., 2021). Dubois et al. (2021) have shown, as well, that diagnosing AD remains a critical challenge for physicians. This leads to significant health inequalities for American
Scientists are racing to find a cure as millions of people reach the age when Alzheimer's is most commonly manifested (Plontz). Experts are still trying to fully understand the cause or causes of Alzheimer's disease. In the meantime, it's helpful to understand the hallmarks of Alzheimer's -- plaques and tangles -- and the risk factors that affect a person's likelihood of developing the disease (Hill). Alzheimer's disease is characterized by a
Elder Adults Alzheimer's disease is a brain disease that is irreversible and progressive which destroys memory and thinking skills slowly and eventually the ability of carrying out even the simplest tests.in most people with Alzheimer's, the symptoms first appear when one is over the age of 60 years. This is the most common cause of dementia among old people (Alzheimer's Association,2012). Diagnosis of Alzheimer's in elderly adult As we have seen, age
Tea as an Antioxidant Tea is an aromatic drink that is usually prepared by soaking or pouring water over plant products, typically the tea plant, but also may be infused with other dried herbs, roots, or extracts. After plain water, tea is consumed more than any other drink globally, including soft drinks. It has a slightly bitter, astringent flavor, sometimes floral, sometimes metallic, that people find enjoyable and often relaxing or,
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now